Navigation Links
Studies in Cell Transplantation investigate oxygen's impact as a factor in transplantation
Date:11/15/2012

Putnam Valley, NY. (Nov. 15, 2012) Two studies published in the current issue of Cell Transplantation (21:7), now freely available on-line at http://www.ingentaconnect.com/content/cog/ct/, investigate the role of oxygen in cell transplantation.

In a study carried out at Baylor University, researchers concerned about the poor efficacy of islet cell transplantation during pancreas preservation and islet isolation have found that low temperatures can prevent hypoxia (low oxygen) that can damage islet cells. In a second study, Brazilian researchers found that neural cells derived from induced pluripotent stem cells generated from skin fibroblasts of a schizophrenic patient show extra oxygen consumption and elevated levels of "reactive oxygen species."

Low temperature prevents hypoxia-induced damage

According to a Baylor University, Texas research team, a major problem in islet cell transplantation is the poor condition of islet cells attributed to hypoxia during cell preservation and isolation.

"Islet cells are highly sensitive to hypoxic conditions," said study co-author Dr. Shinichi Matsumoto of the Baylor Research Institute's Islet Cell Laboratory. "We hypothesized that low temperature conditions could prevent hypoxia induced islet cell damage since cold conditions prevented the release of high levels of high-mobility group box 1 protein (HMGB1)."

Studies related to developing better results are limited, said the researchers, although cold preservation has been applied.

In this study, carried out using mouse models, the research team stored islets at 37oC, 22oC and 4oC. Results showed that the islets stored at 4oC "showed significantly higher insulin secretion" when compared to those stored at 37oC.

"This proved that hypothermic conditions could maintain the islets' ability to secrete insulin, even when exposed to hypoxic damage," said Matsumoto. HMGB1 has been shown to play a role in response to tissue damage, so the researchers also examined HMGB1 expression and the amount of HMGB1 released from each group of islets. They demonstrated that the islets at 37oC up-regulated HMGB1 mRNA, although this was prevented by low temperature conditions. Conversely, the amount of released HMGB1 was "significantly decreased in the cells at 4oC."

The researchers concluded that correspondingly low temperature conditions can prevent hypoxic islet cell damage and that low levels of HMGB1 released from islets might reduce inflammatory responses after transplantation.

"Maintaining low temperature conditions during islet isolation should improve the efficacy of islet isolation in a clinical setting," said the researchers.

Contact: Dr. Shinichi Matsumoto, Baylor Research Institute, Islet Cell Laboratory, 1400 8th Ave., Fort Worth, Texas, 76104.
Email: shinichi41@mac.com

Citation: Itoh, T.; Sugimoto, K.; Takita, M.; Shimoda, M.; Chujo, D.; SoRelle, J. A.; Naziruddin, B.; Levy, M. F.; Matsumoto, S. Low Temperature Condition Prevents Hypoxia-Induced Islet Cell Damage and HMGB1 Release in a Mouse Model. Cell Transplant. 21(7):1361-1370; 2012.

Altered oxygen metabolism associated with iPS cells derived from schizophrenic patient

Researchers found that neural cells derived from induced pluripotent stem cells (iPSCs) generated from skin fibroblasts of a schizophrenic patient demonstrated a twofold increase in extra-mitochondrial oxygen consumption as well as elevated levels of reactive oxygen species (ROS). Their work could contribute to a better understanding of schizophrenia's development as a neurodevelopmental disease, they said.

"Brain mitochondria play a key role in neuroenergetics," said study co-author Dr. Stevens K. Rehen of Brazil's National Laboratory for Embryonic Stem Cell Research. "They are essential regulators of reactive oxygen species (ROS) homeostasis, among other processes. Understanding the role of oxygen metabolism in both the diseased brain and throughout development is critical to elucidating pathophysiological mechanisms in psychiatric disorders." According to the research team, the use of oxygen consumption as an index of oxidative metabolism has been applied for decades and revealed important mechanisms and enzyme activities.

When researchers investigated oxygen consumption and ROS level changes in neural cells derived from the reprogrammed fibroblasts of a schizophrenic patient, their analysis showed "altered extra-mitochondrial oxygen consumption associated with an increase in the levels of ROS."

Our results provide the first evidence of a developmental metabolic alteration in schizophrenia, which can be reverted by pharmacological intervention since the neuroenergetic failure in increased ROS production may have emerged during neural differentiation," said Rehen. They concluded that not only might metabolic changes during neurogenesis contribute to the development of schizophrenia, but might also represent an important target for treatment.

Contact: Dr. Stevens K. Rehen, National Laboratory for Embryonic Stem Cell Research, UFRJ, Hospital Universitario Clementino Fraga Filho HUCFF, Rua Rodolpho Paulo Rocco, 255 4 andar CEPEDIP Cidade Universitaria Rio de Janeiro RJ, Brasil.
Tel. +55-21-2562-2928
Email: srehen@lance-ufrj.org

Citation:. Paulsen, B. da S.; Maciel, R. de M.; Galina, A.; da Silveira, M. S.; Souza, C. dos S.; Drummond, H.; Pozzatto, E. N.; Junior, H. S.; Chicaybam, L.; Massuda, R.; Setti-Perdigo, P.; Bonamino, M.; Belmonte-de-Abreu, P. S.; Castro, N. G.; Brentani, H.; Rehen, S. K. Altered Oxygen Metabolism Associated to Neurogenesis of Induced Pluripotent Stem Cells Derived From a Schizophrenic Patient. Cell Transplant. 21(7):1547-1559; 2012.


'/>"/>

Contact: Robert Miranda
cogcomm@aol.com
Cell Transplantation Center of Excellence for Aging and Brain Repair
Source:Eurekalert

Related biology news :

1. Studies reveal structure of EV71, a virus causing childhood illnesses
2. Collaborative preclinical efficacy studies suggest a new target for drug addiction treatment
3. Autism Speaks awards $1.1 million to fund high priority studies
4. Improving equine health: Research studies vaccinations to protect newborn foals
5. Miniature Sandia sensors may advance climate studies
6. 2 Cell Transplantation studies impact dental stem cell research for therapeutic purposes
7. GSA Bulletin presents studies in Antarctica, Italy, Mexico, Algeria, Mongolia, and more
8. Preclinical studies use specialized ultrasound to detect presence of cancer
9. FirstMark Scientific Board of Advisors Meet to Discuss New Clinical Studies for PREvent
10. New studies show spinal cord injury and ALS respond to cell transplantation
11. First GWAS studies of obsessive-compulsive disorder and Tourette syndrome published
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/2/2016)... , Feb. 2, 2016   Parabon ... from the U.S. Army Research Office and the ... range and sensitivity of the company,s Snapshot ... Accounting Mission and, more generally, defense-related DNA forensics. ... phenotyping capabilities (predicting appearance and ancestry from DNA ...
(Date:1/28/2016)... 2016 Synaptics (NASDAQ: SYNA ), a leading developer ... quarter ended December 31, 2015. --> ... 2016 increased 2 percent compared to the comparable quarter last year ... 2016 was $35.0 million, or $0.93 per diluted share. ... the first quarter of fiscal 2016 grew 9 percent over the ...
(Date:1/22/2016)... , Jan. 22, 2016 ... addition of the "Global Biometrics Market ... their offering. --> http://www.researchandmarkets.com/research/p74whf/global_biometrics ... "Global Biometrics Market in Retail Sector ... --> Research and Markets ( ...
Breaking Biology News(10 mins):
(Date:2/11/2016)... -- Vermillion, Inc. (NASDAQ: VRML ), a bio-analytical solutions ... of the Steering Committee for its Pelvic Mass Registry. ... Pelvic masses can present physicians and healthcare professionals with ... ruled out, pelvic masses may include cancers of the ... tumors and gastrointestinal and urinary tract masses. ...
(Date:2/11/2016)... Feb. 11, 2016  Wellcentive today announced it ... Portland, Oregon -based community care organization (CCO) ... health analytics, quality reporting and care management solutions ... its team of quality managers, analysts and care ... provider groups serving FamilyCare members. ...
(Date:2/11/2016)... , Feb. 11, 2016   BioInformant ... report, "Stem Cell Research Products, Opportunities, Tools, and Technologies ... ... in the stem cell industry, BioInformant has more than ... the stem cell market, by stem cell type. This ...
(Date:2/10/2016)... 2016 /PRNewswire/ - BioAmber Inc. (NYSE: BIOA ), ... that Mitsui & Co. Ltd., its partner in the ... is investing an additional CDN$25 million in the joint ... from 30% to 40%.  Mitsui will also play a ... in Sarnia , providing dedicated resources ...
Breaking Biology Technology: